FY7 POLYMERASE

Abstract: A purified recombinant thermostable DNA polymerase which exhibits at least about 80 % activity at salt concentrations of 50 mM and greater, at least about 70 % activity at salt concentrations of 25 mM and greater, and having a processivity of about 30 nucleotides per binding event. An isolated nucleic acid that encodes the thermostable DNA polymerase, as well as a recombinant DNA vector comprising the nucleic acid and a recombinant host cell transformed with the vector, are also disclosed. A method of sequencing DNA using the DNA polymerase as well as a kit for sequencing DNA is also disclosed.

Description: FY7 POLYMERASE CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to United States Provisional Application Serial No. 60/089,556, filed on June 17, 1998, the entire disclosure of which is incorporated in its herein. BACKGROUND OF THE INVENTION Field of the Invention The instant disclosure pertains to thermostable DNA polymerases which exhibit improved robustness and efficiency. Background DNA polymerases are enzymes which are useful in many recombinant DNA techniques such as nucleic acid amplification by the polymerase chain reaction ("PCR"), self- sustained sequence replication ("3SR"), and high temperature DNA sequencing. Thermostable polymerases are particularly useful. Because heat does not destroy the polymerase activity, there is no need to add additional polymerase after every denaturation step. However, many thermostable polymerases have been found to display a 5' to 3' exonuclease or structure-dependent single-stranded endonuclease ("SDSSE") activity which may limit the amount of product produced or contribute to the plateau phenomenon in the normally exponential accumulation of product. Such 5' to 3' nuclease activity may contribute to an impaired ability to efficiently generate long PCR products greater than or equal to lOkb, particularly for G+C rich targets. In DNA sequencing applications and cycle sequencing applications, the presence of 5' to 3' nuclease activity may contribute to a reduction in desired band intensities and/or generation of spurious or background bands. Additionally, many of the enzymes presently available are sensitive to high salt environments, a condition commonly Presently available enzymes have so-so processing ability (are more distributive - fall off more often - explain in more detail) dITP added to address compression problems - usually kills activity of enzyme Thus, a need continues to exist for an improved DNA polymerase having increased tolerance to high salt conditions, efficient utilization of dITP, high productivity, and improved performance on GC-rich templates. BRIEF SUMMARY OF THE INVENTION The instant disclosure teaches a purified recombinant thermostable DNA polymerase comprising the amino acid sequence set forth in Figure 1 , as well as a purified recombinant thermostable DNA polymerase which exhibits at least about 80% activity at salt concentations of 50 mM and greater. The instant disclosure further teaches a purified recombinant thermostable DNA polymerase which exhibits at least about 70% activity at salt concentrations of 25 mM and greater, and a purified recombinant thermostable DNA polymerase having a processivity of about 30 nucleotides per binding event. The instant disclosure also teaches an isolated nucleic acid that encodes a thermostable DNA polymerase. wherein said nucleic acid consists of the nucleotide sequence set forth in Figure 1 , as well as a recombinant DNA vector that comprises the nucleic acid, and a recombinant host cell transformed with the vector. The instant disclosure also teaches a method of sequencing DNA comprising the step of generating chain terminated fragments from the DNA template to be sequenced with the DNA polymerase in the presence of at least one chain terminating agent and one or more nucleotide triphosphates, and determining the sequence of said DNA from the sizes of said fragments. The instant disclosure also teaches a kit for sequencing DNA comprising the DNA polymerase. BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS FIGURE 1 depicts the amino acid sequence (and DNA sequence encoding therefor) for the FY7 polymerase. FIGURE 2 depicts the DNA sequence of M13mpl8 DNA sequenced using the FY7 polymerase formulated in Mn conditions, as shown by a print out from an ABI model 377 automated fluorescent DNA sequencing apparatus. FIGURE 3 depicts the DNA sequence of M13mpl8 DNA sequenced using the FY7 polymerase formulated in Mg conditions, as shown by a print out from an ABI model 377 automated fluorescent DNA sequencing apparatus. FIGURE 4 depicts the percent of maximum polymerase activity for Thermo Sequenase™ enzyme DNA polymerase versus FY7 DNA polymerase under varying_KCl concentrations. FIGURE 5 depicts the effect of high salt concentrations on DNA sequencing ability in radioactively labeled DNA sequencing reactions using Thermo Sequenase™ enzyme DNA polymerase versus FY7 DNA polymerase. FIGURES 6-10 depict the effect of increasing salt concentration on the performance of Thermo Sequenase. At concentrations as low as 25mM data quality is affected with the read length being decreased from at least 600 bases to about 450 bases. At 50mM salt the read length is further decreased to about 350 bases, 75mM to about 250 bases and at lOOmM the read length is negligible. FIGURES 11-15 depict the effect of increasing salt concentration on the performance of FY7 DNA polymerase. There is no detrimental effect on performance to at least 75mM KCl and only a slight decrease in data quality at lOOmM KCl. FIGURE 16 depicts the processivity measured for Thermo Sequenase DNA polymerase, AmpliTaq FS DNA polymerase, compared with the processivity measured for FY7 DNA polymerase. FIGURE 17 depicts the improved read length obtained when using FY7 polymerase versus Thermo Sequenase DNA polymerase in radioactively labeled sequencing reactions incorporating the dGTP (Guanosine triphosphate) analog dITP (Inosine triphosphate) at 72 °C. FIGURES 18-22 show the effect of increasing extension step time on the read length and data quality produced by Thermo Sequenase DNA polymerase in fluorescently labeled terminator DNA sequencing reactions FIGURES 23-27 show the effect of increasing extension step time on the read length and data quality produced by FY7 DNA polymerase in fluorescently labeled terminator DNA sequencing reactions. DETAILED DESCRIPTION OF THE INVENTION A series of polymerase mutants were constructed with the aim of obtaining an improved polymerase for DNA sequencing, by reducing the exonuclease activity found in full length Thermus thermophilus and Thermus aquaticus DNA polymerase I enzymes. Six conserved motifs (Gutman and Minton (1993) Nucleic Acids Research 21, 4406 - 4407) can be identified in the amino-terminal domain of pol I type polymerases, in which the 5' to 3' exonuclease activity has been shown to reside. Further, six carboxylate residues in these conserved regions have been shown in a crystal structure to be located at the active site of the exonuclease domain of Thermus aquaticus DNA pol I (Kim et al., (1995) Nature 376, 612- 616). Point mutations were made by site-directed mutagenesis to carboxylates and other residues in three of six conserved motifs in Tth and Taq polymerases as follows: Taq D18A, Taq T140V, Taq D142N/D144N. All of these have the mutation F667Y outside of the exonuclease domain. Tth D18A, Tth T141V, Tth D143N/D145N. All of these have the mutation F669Y outside of the exonuclease domain. All polymerases were evaluated for exonuclease activity, processivity, strand displacement, salt tolerance, thermostability, and sequencing quality. One FY7 polymerase, Tth D18A, F669Y, is described in further detail below. EXAMPLES Methods In vitro mutaeenesis PCR was employed to introduce an aspartic acid to alanine amino acid change at codon 18 (D18A) of cloned full length F669Y Tth (plasmid pMRlO). Mutagenic Primer 1 (CTGTTCGAACCCAAAGGCCGTGTCCTCCTGGTGGCCGGCCACCAC) spans nucleotides 19-60 of pMRlO including codon 18 and a .RstBI restriction site. Oligonucleotide Primer 2 (GAGGCTGCCGAATTCCAGCCTCTC) spans an EcoRI site of pMRlO. pMRlO was used as template DNA. The PCR product was digested with BstBl and EcoRI and ligated to two fragments of pMRlO: a 5000 bp Kpnll BstBl and a 2057 bp EcoRI / Kpnl, creating plasmid pMR12. Cells of E coli strain DHlλ + were used for primary transformation, and strain M5248 (λ cI857) was used for protein expression, although any comparable pair of E. coli strains carrying the cl + and cI857 alleles could be utilized. Alternatively, any rec + cl + strain could be induced by chemical agents such as nalidixic acid to produce the polymerase. Purification of Polymerase M5248 containing plasmid pMR12 was grown in one liter of LB medium (1% tryptone. 0.5% yeast extract. 1% NaCl), preferably 2X LB medium, containing 100 mg ml ampicillin at 30°C. When the OD 6 oo reached 1.0, the culture was induced at 42°C for 1.5 hours. The cultures were then cooled to <20°C and the cells harvested by centrifugation in a Sorvall RC-3B centrifuge at 5000 rpm at 4°C for 15 to 30 minutes. Harvested cells were stored at -80°C. The cell pellet was resuspended in 25 ml pre-warmed lysis buffer (50 mM Tris-HCI pH 8.0, 10 mM MgCl 2 , 16 mM (NH 4 ) 2 S0 4 , 1 mM ΕDTA, 0.1%. preferably 0.2% Tween 20, 0.1%, preferably 0.2% NP40). Preferably, the lysis buffer contains 300 mM NaCl. Resuspended cells were incubated at 75 - 85°C for 10-20 minutes, sonicated for 1 minute, and cleared by centrifugation. The cleared lysate was passed through a 300 ml column of diethylaminoethyl cellulose (Whatman DE 52) equilibrated in buffer A (50mM Tris-HCl pH 8.0, ImM EDTA. 0.1% Tween 20, 0.1% NP40) containing lOOmM, preferably 300 mM NaCl. Fractions were assayed for polymerase activity, and those demonstrating peak polymerase activity were pooled, diluted to 50 mM NaCl with Buffer A, and loaded onto a heparin sepharose column (20 ml) equilibrated with 50 mM NaCl in buffer A. The polymerase was eluted from the column with a linear salt gradient from 50 mM to 700mM NaCl in buffer A. Fractions were assayed for polymerase activity, and those demonstrating peak activity were pooled and dialyzed against final buffer (20mM Tris-HCl pH8.5, 50 % (v/v) glycerol, O.lmM EDTA, 0.5% Tween 20. 0.5% NP40, ImM DTT, lOOmM KCl). The purified protein is designated FY7. The amino acid sequence (and DNA sequence encoding therefor) are presented in Figure 1. Bacterial Strains E. coli strains: DHIλ + [gyrA96, recAl. relAl. endAl, thi-1, hsdR17. supE44, λ"]; M5248 [λ (bio275. cI857, cIII+, N+, λ (HI))]. PCR Plasmid DNA from E. coli DHIλ τ (pMRlO) was prepared by SDS alkaline lysis method (Sambrook et al., Molecular Cloning 2 nd Ed. Cold Spring Harbor Press, 1989). Reaction conditions were as follows: 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.001% gelatin. luM each primer, 2.5U Taq polymerase, per 100 μl reaction. Cycling conditions were 94°C 2 minutes, then 35 cycles of 94°C 30s, 55°C 30s, 72°C 3 minutes, followed by 72°C for 7 minutes. Example 1 Formulation of the enzyme in Mn conditions In the following "pre-mix" protocol, all the reagents are contained in two solutions; reagent mix A and reagent mix B. Reagent Mix A The following reagents were combined to make 10 ml of reagent mix A: 2.5 ml 1 M HEPPS N-(2-hydroxyethyl) piperazine-N'-(3-propanesulfonic acid), pH 8.0 500 μl 1 M tartaric acid, pH 8.0 50,000 units FY7 DNA polymerase 1 unit Thermoplasma acidophilum inorganic pyrophosphatase lOO μl lOO mM dATP 100 μl lOO mM dTTP 100 μl lOO mM dCTP 500 μl lOO mM dITP 9.375 μl 100 μM C-7-propargylamino-4-rhodamine-6-G-ddATP 90 μl 100 μM C-5-propargylamino-4-rhodamine-X-ddCTP 6.75 μl 100 μM C-7-propargylamino-4-rhodamine-110-ddGTP 165 μl 100 μM C-5-propargylamino-4-tetramethylrhodamine-ddUTP 10 μl 50 mM EDTA 1 ml glycerol The volume was made up to 10.000 μl with deionized H O. Reagent Mix B The following reagents were combined to make 10 ml of reagent mix B: 10 μl 1M MES 2-(N-morpholino ethanesulfonic acid, pH 6.0 200 μl IM MgCh 75 μl lM MnSO 4 The volume was made up to 10.000 μl with deionized H 2 0. Example 2: Use of the formulation from Example 1 Two (2) μl reagent mix A, 2 μl reagent mix B, 200 ng M13mpl8 DNA, 5 pmole of primer (Ml 3 - 40 Forward 5'-GTTTTCCCAGTCACGACGTTGTA), and deionized water to a total volume of 20 μl were mixed together and subjected to 25 cycles of (95 °C 30 seconds, 60 °C 1 minute) in a thermal cycler. After cycling, 4 μl of a solution which contained 1.5 M sodium acetate. 250 mM EDTA was added. The solution was mixed and 4 volumes (100 μl) of ethanol added. The DNA was precipitated by incubation on ice for 15-20 minutes followed by centrifugation. The supernatant was removed and the pellet was washed with 70% ethanol, dried and resuspended in 4 μl of formamide containing loading dye. The resuspended DNA was then run on an automated fluorescent DNA sequencing apparatus (ABI model 377 instrument). The print out from the machine of the DNA sequence is shown as Figure 2. Example 3 Formulation of the enzvme in Mg conditions In the following "pre-mix" protocol, all the reagents are contained in one solution. Sequencing premix The following reagents were combined to make 800 μl of Sequencing premix 200 μl of 500 mM Tris-HCl pH 9.5, 20 mM MgCl 2 100 μl 40 units/μl FY7 DNA polymerase. 0.0008 units/μl Thermoplasma acidophilum inorganic pyrophosphatase 100 μl 10 mM dITP, 2 mM dATP, 2 mM dTTP. 2 mM dCTP 100 μl 0.125 μM C-7-propargylamino-4-rhodamine-6-G-ddATP 100 μl 1.2 μM C-5-propargylamino-4-rhodamine-X-ddCTP 100 μl 0.09 μM C-7-propargylamino-4-rhodamine-110-ddGTP 100 μl 2.2 μM C-5-propargylamino-4-tetramethylrhodamine-ddUTP Example 4 Use of the formulation from example 3 Four (4) μl of sequencing premix, 200 ng M13mpl8 DNA, 5 pmole of primer (M13 - 40 Forward 5'- GTTTTCCCAGTCACGACGTTGTA), and deionized water to a total volume of 20 μl were mixed together and subjected to 25 cycles of (95 °C 30 seconds, 60 °C 2 minutes) in a thermal cycler. After cycling, 7 μl of 7.5 M ammonium acetate was added. The solution was mixed and 4 volumes (100 μl) of ethanol added. The DNA was precipitated by incubation on ice for 15-20 minutes followed by centrifugation. The supernatant was removed and the pellet was washed with 70% ethanol, dried and resuspended in 4 μl of formamide containing loading dye. The resuspended DNA was then run on an automated fluorescent DNA sequencing apparatus (ABI model 377 instrument). The print out from the machine of the DNA sequence is shown as Figure 3. Example 5 Polymerase Activity versus Salt Concentration (KCl) for Thermo Sequenase™ enzyme and FY7 enzyme. The percent of maximum polymerase activity was measured for Thermo Sequenase™ enzyme DNA polymerase and FY7 DNA polymerase under varyingJ Cl concentrations. The results are depicted in Figure 4. The data indicate that FY7 has a much higher salt optimum as well as broader range of tolerance for salt in the reaction mixture than Thermo Sequenase™. The salt concentration which gives 50% activity is five-fold higher for FY7 than for Thermo Sequenase. The effect of high salt concentrations on DNA sequencing ability in radioactively labeled DNA sequencing reactions was also examined. The results are presented in Figure 5. At KCl concentrations of 50mM or higher Thermo Sequenase™ polymerase performance degrades to levels at which usable data cannot be extracted. FY7 DNA polymerase, however, is able to give quite good sequencing data at concentrations of KCl of lOOmM. Example 6 Fluorescent Sequencing Salt Tolerance These experiments examined the effect of the above-demonstrated polymerase activity in high salt concentrations on DNA sequencing ability in fluorescently labeled terminator DNA sequencing reactions. The results are presented in Figures 6-15. Figures 6-10 show the effect of increasing salt concentration on the performance of Thermo Sequenase. At concentrations as low as 25mM data quality is affected with the read length being decreased from at least 600 bases to about 450 bases. At 50mM salt the read length is further decreased to about 350 bases, 75mM to about 250 bases and at lOOmM the read length is negligible. Figures 11-15 show the effect of increasing salt concentration on the performance of FY7 DNA polymerase. There is no detrimental effect on performance to at least 75mM KCl and only a slight decrease in data quality at lOOmM KCl. As it is recognized that some types of DNA preparations may be contaminated with salt (which is detrimental to DNA sequencing data quality), the use of FY7 DNA polymerase allows for a more robust sequencing reaction over a broader range of template conditions. Example 7 Polymerase Processivity The processivity (number of nucleotides incorporated per DNA polymerase binding event) has been measured, for different DNA sequencing polymerases. The results are presented in Figure 16. Thermo Sequenase DNA polymerase has a processivity of only -4 nucleotides per binding event. AmpliTaq FS DNA polymerase has a processivity of - 15 nucleotides per binding event. FY7 DNA polymerase has a processivity more than seven-fold greater than Thermo Sequenase DNA polymerase and -two-fold greater than AmpliTaq FS DNA polymerase at -30 nucleotides per binding event. Example 8 Polymerase Extension with dITP at 72 °C The series examined improved read length obtained when using FY7 polymerase versus Thermo Sequenase DNA polymerase in radioactively labeled sequencing reactions incorporating the dGTP (Guanosine triphosphate) analog dITP (Inosine triphosphate) at 72 °C. The results are presented in Figure 17. FY7 is able to incorporate >50-100 more nucleotides under standard j3 P[α-dATP] sequencing conditions than Thermo Sequenase. Example 9 Effect of Extension Step Time on Length of Read These series of experiments examined the effect of increasing extension step time of the read length and data quality of Thermo Sequenase and FY7 DNA polymerases in fluorescently labeled terminator DNA sequencing reactions. The results are presented in Figures 18-27. Figures 18-22 show the effect of increasing extension step time on the read length and data quality produced by Thermo Sequenase DNA polymerase. This data shows that a minimum of a two minutes extension step is required by Thermo Sequenase in order to achieve a quality read of at least 600 bases. Signal strength generally increases to a maximum at a four minute extension (the time specified in the commercial product utilizing this enzyme and method). Figures 23-27 show the effect of increasing extension step time on the read length and data quality produced by FY7 DNA polymerase. This data shows that a minimum of a 30 second extension step is required by FY7 in order to achieve a quality read of at least 600 bases. Signal strengths plateau at about one minute extension time. The FY7 DNA polymerase can produce data of equivalent quality to Thermo Sequenase in one-quarter to one-half the time of extension reaction. Although the above examples describe various embodiments of the invention in detail, many variations will be apparent to those of ordinary skill in the art. Accordingly, the above examples are intended for illustration purposes and should not be used in any way to restrict the scope of the appended claims.

Claims: CLAIMS What is claimed is: 1. A purified recombinant thermostable DNA polymerase comprising the amino acid sequence set forth in Figure 1. 2. A purified recombinant thermostable DNA polymerase which exhibits at least about 80% activity at salt concentations of 50 mM and greater. 3. A purified recombinant thermostable DNA polymerase which exhibits at least about 70% activity at salt concentrations of 25 mM and greater. 4. A purified recombinant thermostable DNA polymerase having a processivity of about 30 nucleotides per binding event. 5. An isolated nucleic acid that encodes a thermostable DNA polymerase, wherein said nucleic acid consists of the nucleotide sequence set forth in Figure 1 6. A recombinant DNA vector that comprises the nucleic acid of Claim 3. 7. The recombinant DNA sequence of Claim 4 comprising the plasmid pMRl 0. 8. A recombinant host cell transformed with the vector of Claim 5. 9. The recombinant host cell of Claim 6 that is E. coli. 10. The recombinant host cell of Claim 7 which is Ε. coli carrying the cl + and cI857 alleles. 11. The recombinant host cell of Claim 7 selected from the group consisting of DHIλ τ [gyrA96, recAl. relAl, endAl, thi-1, hsdR17. supΕ44. λ"] and M5248 [λ (bio275, cI857. cIII+, N+. λ (Hl))]. 12. Method of sequencing DNA comprising the step of generating chain terminated fragments from the DNA template to be sequenced with the DNA polymerase of Claim 1 in the presence of at least one chain terminating agent and one or more nucleotide triphosphates. and determining the sequence of said DNA from the sizes of said fragments. 3. A kit for sequencing DNA comprising the DNA polymerase of Claim 1.

Inventors: DAVIS MARIA, FULLER CARL W, HUANG LIN, MAMONE JOSEPH A, DAVIS, MARIA, FULLER, CARL, W., HUANG, LIN, MAMONE, JOSEPH, A.
Applicants: AMERSHAM PHARM BIOTECH INC, AMERSHAM PHARMACIA BIOTECH INC.
Application year: 1999
Main classification: C07K14
IPC codes: C12N1, C12N9, C12N15, C12Q1, C12R1